Ribosomal protein L9 pseudogene 30 (RPL9P30)

Ribosomal protein L9 pseudogene 30 (RPL9P30) is a non-functional pseudogene found in the human genome and is related to the ribosomal protein L9 gene, which encodes a component of the large 60S ribosomal subunit involved in protein synthesis[1][2]. Unlike functional genes, pseudogenes such as RPL9P30 are genomic DNA sequences similar to known genes but typically lack regulatory elements or code-disrupting mutations that prevent them from producing active proteins; thus, they do not participate in biological processes, disease, drug interactions, or therapeutic mechanisms[1][2]. This pseudogene is among many processed pseudogenes of ribosomal protein genes found in the genome, reflecting evolutionary history and gene duplication events[3][5][8]. Clarification: RPL9P30 is sometimes confused with RPL9, a real ribosomal protein gene involved in ribosome function and disease (such as Diamond-Blackfan anemia)[5][8], but RPL9P30 itself is not expressed as a protein, is not part of any biological pathway, and is not considered a target for pharmaceutical intervention[1][2]. For structured data, entries for therapeutic or mechanistic roles should remain null. Summary: RPL9P30 is a pseudogene with no recognized biological, therapeutic, or diagnostic importance. Any information suggesting it is a drug target or functional gene is incorrect[1][2].

Other names

RPL9_11_1536RPL9P30

None (not a drug target)